(Q54159163)

25 May 2018

title

Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence. (English)

1 reference

25 May 2018

author name string

Perner F

1

1 reference

25 May 2018

Gyuris T

2

1 reference

25 May 2018

Rákóczy G

3

1 reference

25 May 2018

Sárváry E

4

1 reference

25 May 2018

Görög D

5

1 reference

25 May 2018

Szalay F

6

1 reference

25 May 2018

Kunos I

7

1 reference

25 May 2018

Szönyi L

8

1 reference

25 May 2018

Péterfy M

9

1 reference

25 May 2018

Takács L

10

1 reference

25 May 2018

publication date

1 July 1999

1 reference

25 May 2018

published in

Translational Research

1 reference

25 May 2018

volume

134

1 reference

25 May 2018

issue

1

1 reference

25 May 2018

page(s)

56-67

1 reference

25 May 2018

Dipeptidyl peptidase (DPP) IV in rat organs. Comparison of immunohistochemistry and activity histochemistry

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Organ distribution of aminopeptidase A and dipeptidyl peptidase IV in normal mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Immunoelectron microscopic single and double labelling of aminopeptidase N (CD 13) and dipeptidyl peptidase IV (CD 26)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Serum enzyme tests in diseases of the liver and biliary tree

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Biliary atresia: current concepts and research directions. Summary of a symposium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Biliary atresia into the 21st century: a historical perspective

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Increased urinary dipeptidyl peptidase IV activity in extrahepatic biliary atresia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Deficiency of membrane-bound dipeptidyl aminopeptidase IV in a certain rat strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Studies of thymocytopoiesis in rats and mice. I. Kinetics of appearance of thymocytes using a direct intrathymic adoptive transfer assay for thymocyte precursors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

glycylprolyl β-naphthylamidase activity in human serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Glycylprolyl-diaminopeptidase in human leukocytes: selective occurrence in T lymphocytes and influence on the total serum enzyme activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Serum dipeptidyl peptidase activities as a possible marker of oral cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Decreased serum dipeptidyl peptidase IV activity in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Enhancement of antigen-induced T-cell proliferation by soluble CD26/dipeptidyl peptidase IV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Colorimetrical rate assay for urinary dipeptidyl peptidase IV (DPPIV) activity using a new substrate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Changes in form of dipeptidyl-aminopeptidase IV in urine from patients with renal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Changes in serum dipeptidyl-aminopeptidase IV (glycylprolyl dipeptidyl-aminopeptidase) activity of patients with gastric carcinoma after surgical excision and the enzyme activity in the carcinoma tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Potentiation of the immune response in HIV-1+ individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Effects of different bile salts upon the composition and morphology of a liver plasma membrane preparation. Deoxycholate is more membrane damaging than cholate and its conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

The activity of γ-glutamyltransferase after bile duct ligation in guinea pig

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Proline-dependent structural and biological properties of peptides and proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

A Novel Form of Dipeptidylpeptidase IV Found in Human Serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in patients with primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Molecular mechanisms of cholestasis: causes and consequences of impaired bile formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Increased serum levels of dipeptidyl peptidase IV (CD26) in rats undergoing liver regeneration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1alpha (SDF-1alpha) and SDF-1beta are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2899%2990054-9

10.1016/S0022-2143(99)90054-9

7 January 2021

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018